US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist
  • 5.535
  • -0.205-3.57%
Trading Nov 29 12:35 ET
379.41MMarket Cap-1448P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Amylyx Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
0
416.00K
+416.00K
Beat Est.
-100.00%
-99.59%
--
EPS
-0.56
-1.07
-0.51
Miss Est.
-288.30%
-456.67%
-89.41%
Buy

Nov 29, 2024

Amylyx Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q3416.000K / 0.000--
Aug 8, 20242024/Q2-1.023M / 8.530M--
May 9, 20242024/Q188.643M / 98.346M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q3416.000K / 0.000--
Aug 8, 20242024/Q2-1.023M / 8.530M--
May 9, 20242024/Q188.643M / 98.346M--

Unlock Free Earnings Estimates

Amylyx Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 29, 2024

Buy

  • Buy

    60.00%
  • Hold

    40.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data